|
Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
IDA |
|
RGD |
PMID:15771619 |
RGD:1358145 |
NCBI chr 1:153,136,852...260,522,016
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
IDA |
|
RGD |
PMID:15771619 |
RGD:1358145 |
NCBI chr 1:153,136,852...260,522,016
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:193,422,268...214,537,671
|
|
Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:214,537,555...226,660,468
|
|
Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
|
|
Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:70,808,386...115,808,386
|
|
Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:123,143,783...168,143,783
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|